1–9 boxes
$216.00 each
10–24 boxes
8% off
25+ boxes
10% off
Erdafitinib 3mg Tablets
SKU GME166Product Introduction
Erdafitinib 3mg is a targeted anticancer medicine used for selected cancers with susceptible FGFR genetic alterations when erdafitinib is prescribed by an oncology specialist. It inhibits fibroblast growth factor receptors, which can drive tumor growth in some cancers such as urothelial carcinoma with qualifying alterations.
How to use
Take Erdafitinib 3mg exactly as the oncology team prescribes. Do not start unless FGFR alteration status, monitoring, and dose plan are confirmed.
How it works
Erdafitinib inhibits FGFR signalling pathways that can promote growth of tumours with susceptible FGFR alterations.
Common side effects
Possible effects include mouth sores, diarrhea, dry mouth, nail changes, dry skin, fatigue, high phosphate, and appetite changes. Serious concerns include retinal disorders, severe eye symptoms, embryo-fetal harm, and significant lab abnormalities.
Important information
Review FGFR test result, cancer indication, eye exams, phosphate level, kidney/liver tests, pregnancy prevention, breastfeeding avoidance, CYP interactions, phosphate binders, and visual symptoms.
Uses
Selected FGFR-altered cancers when prescribed by an oncology specialist.
Benefits
Targets FGFR-driven cancer biology in biomarker-selected patients with specialist monitoring.
What is Erdafitinib 3mg used for?
It is used only for selected FGFR-altered cancers when an oncology specialist confirms that the indication and monitoring plan fit.
How should Erdafitinib 3mg be used?
Take Erdafitinib 3mg exactly as the oncology team prescribes. Do not start unless FGFR alteration status, monitoring, and dose plan are confirmed.
What should be checked before Erdafitinib 3mg?
Tell your doctor about FGFR test result, cancer indication, eye exams, phosphate level, kidney/liver tests, pregnancy prevention, breastfeeding avoidance, CYP interactions, phosphate binders, and visual symptoms.
What side effects should be watched with Erdafitinib 3mg?
Side effects can include mouth sores, diarrhea, dry mouth, nail changes, dry skin, fatigue, high phosphate, and appetite changes. Seek urgent medical advice for retinal disorders, severe eye symptoms, embryo-fetal harm, and significant lab abnormalities.
Erdafitinib, FGFR inhibitor, Targeted cancer therapy, Urothelial carcinoma, Phosphate monitoring, Retinal toxicity warning, AR: Erdafitinib أقراص, FR: Erdafitinib comprimé, PT: Erdafitinib comprimido, ES: Erdafitinib tableta, RU: Erdafitinib таблетки, ID: Erdafitinib, VI: Erdafitinib viên nén, MS: Erdafitinib, TL: Erdafitinib tableta, ZH-SG: Erdafitinib 片剂
